Search Results - "Minzi, Omary S"

Refine Results
  1. 1

    Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary S, Kinung'hi, Safari M, Kamuhabwa, Appolinary A, Aklillu, Eleni

    Published in PloS one (05-02-2020)
    “…Schistosomiasis is a neglected tropical disease that continues to cause morbidity and mortality in Sub Saharan Africa. Due to its endemicity, co-infection with…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Homann, Manijeh V, Färnert, Anna, Aklillu, Eleni

    Published in Malaria journal (03-07-2017)
    “…Pregnancy has considerable effects on the pharmacokinetic properties of drugs used to treat uncomplicated Plasmodium falciparum malaria. The role of…”
    Get full text
    Journal Article
  4. 4

    Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin by Minzi, Omary M. S, Lyimo, Tatu E, Furia, Francis F, Marealle, Alphonce I, Kilonzi, Manase, Bwire, George M, Malichewe, Christina

    Published in BMC pharmacology & toxicology (23-09-2020)
    “…Background Cisplatin is an important drug in the treatment of various Cancers. However, this drug causes nephrotoxicity that is linked to electrolyte…”
    Get full text
    Journal Article
  5. 5

    Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women by Mutagonda, Ritah F, Kamuhabwa, Appolinary A R, Minzi, Omary M S, Massawe, Siriel N, Maganda, Betty A, Aklillu, Eleni

    Published in Malaria journal (13-05-2016)
    “…Day 7 plasma concentrations of lumefantrine (LF) can serve as a marker to predict malaria treatment outcome in different study populations. Two main cut-off…”
    Get full text
    Journal Article
  6. 6

    Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania by Mnkugwe, Rajabu Hussein, Minzi, Omary S, Kinung'hi, Safari M, Kamuhabwa, Appolinary A, Aklillu, Eleni

    Published in Pathogens (Basel) (01-01-2020)
    “…Single-dose targeted praziquantel preventive chemotherapy is the WHO-recommended intervention for schistosomiasis control in endemic countries. The objective…”
    Get full text
    Journal Article
  7. 7

    Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations by Mutagonda, Ritah F, Minzi, Omary M S, Massawe, Siriel N, Asghar, Muhammad, Färnert, Anna, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in Drug metabolism and disposition (01-12-2019)
    “…Pregnancy and pharmacogenetics variation alter drug disposition and treatment outcome. The objective of this study was to investigate the effect of pregnancy…”
    Get full text
    Journal Article
  8. 8

    Adoption of the new antimalarial drug policy in Tanzania – a cross‐sectional study in the community by Eriksen, Jaran, Nsimba, Stephen E. D., Minzi, Omary M. S., Sanga, Anku J., Petzold, Max, Gustafsson, Lars L., Warsame, Marian Y., Tomson, Göran

    Published in Tropical medicine & international health (01-10-2005)
    “…Summary Objective  To assess the diffusion of the change of first line antimalarial drug from chloroquine (CQ) to sulphadoxine/pyrimethamine (SP) at household…”
    Get full text
    Journal Article
  9. 9

    The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment by Maganda, Betty A, Ngaimisi, Eliford, Kamuhabwa, Appolinary A R, Aklillu, Eleni, Minzi, Omary M S

    Published in Malaria journal (25-04-2015)
    “…HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with both artemether-lumefantrine (AL) and efavirenz (EFV) or nevirapine…”
    Get full text
    Journal Article
  10. 10

    Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations by Marwa, Karol J, Schmidt, Theresa, Sjögren, Maria, Minzi, Omary M S, Kamugisha, Erasmus, Swedberg, Göte

    Published in Malaria journal (03-11-2014)
    “…Artemisinin-based combinations currently recommended for treatment of uncomplicated Plasmodium falciparum malaria in many countries of sub-Saharan Africa are…”
    Get full text
    Journal Article
  11. 11

    Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania by Mghamba, Frida William, Minzi, Omary M S, Massawe, Augustine, Sasi, Philip

    Published in BMC pediatrics (15-06-2013)
    “…Adherence to antiretroviral drugs in the treatment of paediatric HIV infection is complicated because of many factors including stigma and drug intake…”
    Get full text
    Journal Article
  12. 12

    Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy by Maganda, Betty A, Minzi, Omary M S, Kamuhabwa, Appolinary A R, Ngasala, Billy, Sasi, Philip G

    Published in Malaria journal (30-05-2014)
    “…Malaria and HIV infections are both highly prevalent in sub-Saharan Africa, with HIV-infected patients being at higher risks of acquiring malaria. The majority…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy by Mlugu, Eulambius M, Minzi, Omary M S, Johansson, Mats, Kamuhabwa, Appolinary A R, Aklillu, Eleni

    Published in BMC pharmacology & toxicology (08-07-2024)
    “…Dihydroartemisinin-piperaquine (DHP) recently showed superior effectiveness over sulfadoxine-pyrimethamine for malaria intermittent preventive treatment in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial by Peter, Emanuel L., Rumisha, Susan F., Mashoto, Kijakazi O., Minzi, Omary MS, Mfinanga, Sayoki

    Published in Journal of ethnopharmacology (14-09-2017)
    “…Indigenous community of Mkuranga district have been using aqueous extract of H. sabdariffa L. for treating anemia. However, there have been neither safety nor…”
    Get full text
    Journal Article
  19. 19

    Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania by Mugusi, Sabina F, Ngaimisi, Eliford, Janabi, Mohamed Y, Mugusi, Ferdinand M, Minzi, Omary M S, Sasi, Philip G, Bakari, Muhammad, Lindquist, Lars, Aklillu, Eleni, Sandstrom, Eric G

    Published in Antiviral therapy (01-01-2012)
    “…The aim of this study was to describe risk factors for mortality and clinical characteristics of HIV-infected patients with and without tuberculosis (TB)…”
    Get more information
    Journal Article
  20. 20

    Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania by Joseph, Deokary, Kabanywanyi, Abdunoor M, Hulser, Ruth, Premji, Zulfiqarali, Minzi, Omary Ms, Mugittu, Kefas

    Published in Malaria journal (11-02-2013)
    “…Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. Recently, there was an anecdotal report on high malaria…”
    Get full text
    Journal Article